Nearly $2B in funding for new Indianapolis VA hospital included in federal budget proposal
The budget proposal calls for a new 840,000-square-foot tower that would replace the aging Richard L. Roudebush Veterans Administration Medical Center.
Health Care & Life Sciences
-
IU researchers play role in development of new bladder cancer treatment
The treatment uses a combination of two drugs to battle the cancer in addition to surgery to remove tumors.
Read More -
Eli Lilly begins using ‘mind-blowing’ LillyPod supercomputer at Indy campus
LillyPod, which occupies 30,000 square feet in a room the size of a football field, is capable of crunching massive amounts of data at high speeds and is expected to help the Lilly discover and develop drugs at a faster pace.
Read More -
Plainfield Fire Territory launches prehospital blood transfusion program
Plainfield is one of 12 Indiana fire departments with prehospital blood transfusion programs in place, preventing potentially fatal blood loss in the field.
Read More -
Lilly, IU sign clinical trial, research agreement worth up to $40M
Officials say the pact, facilitated by the Indianapolis-based IU Launch Accelerator for Biosciences, is the largest single industry-sponsored agreement in the school’s history.
Read More
Articles
Boone County’s Witham Health Services plans to join Parkview Health
Witham’s announcement comes amid a series of recent moves by Parkview Health involving expansion into areas of the state away from its headquarters in Fort Wayne.
Bond trustee sues addiction treatment centers’ operator
Facilities in Greenfield and Knox are at the heart of a lawsuit that seeks to replace the centers’ Indianapolis-based operator, Crossroads Health Management LLC, over allegations of financial mismanagement and revenue diversion.
IU names board of nonprofit for real estate, research and life sciences work
Pamela Whitten, president of Indiana University, will serve as chair of the IU Inc. board of directors.
Construction on $4.3B IU Health hospital campus about 60% complete and on schedule
The 44-acre campus will span from 12th to 16th streets and from Capitol Avenue to Interstate 65 — approximately eight square blocks.
Lilly to acquire UK-based pharmaceutical company in deal worth up to $7.8B
Centessa Pharmaceuticals is developing treatments to address daytime sleepiness and other neurological conditions.
Lilly asks U.S. Supreme Court to rule part of False Claims Act unconstitutional
The Indianapolis-based drugmaker is challenging a $183.7 million judgment in a case brought by a pharmacist who alleged Lilly made false claims about rebates to the federal Medicaid program.
Obesity drug trials complicated by placebo patients leaving early
The companies developing new weight-loss medicines have a problem: People who don’t lose weight quickly figure out they were assigned to take a placebo and are bailing out of their clinical trials.
Indiana plans to cut Medicaid coverage of drugs through federal program
The change is expected to save the state’s Medicaid program approximately $63 million annually, but safety-net care providers say the cuts could put them in jeopardy.
Industry, university leaders design state chemistry strategy
Indiana’s largest life sciences companies and research universities are working to make the state an international leader in chemistry innovation — and they’re ready to launch the first step in a plan called Catalyze Indiana.
Lilly introduces direct-to-employer program for weight-loss drug
Eli Lilly and Co. has launched a platform that offers employers coverage options for obesity care through a partnership with 18 digital health programs.
CICP announces name change but will keep acronym the same
The organization long known as the Central Indiana Corporate Partnership said the new name better reflects the leadership it represents.
Chief technology officer spent whole career at Lilly
Tim Coleman has held positions within information technology at Lilly in research and development, sales and marketing, manufacturing, and human resources.
Indiana life sciences giant Philip Low dies at 78
Low founded seven companies based on intellectual property developed at Purdue, including Endocyte Inc., which he sold to Novartis Inc. in 2018 for $2.1 billion.
CICP launches fund aimed at making Indiana a chemistry hub
The Catalyst Scholars Fund is supported by a $69.4 million grant from Lilly Endowment Inc. to the CICP Foundation Inc. and matching commitments from participating universities.
Indiana puts legislative stop to Elevance’s out-of-network hospital care penalty
Senate Bill 189 took aim at a new policy by Indianapolis-based Elevance Health Inc. that cut hospital reimbursement by 10% if an out-of-network clinician was involved with care.
Anthem Blue Cross and Blue Shield forms local orthopedic care health network
OrthoIndy and Franciscan Health/Forté Sports Medicine and Orthopedics are the first two providers to join Anthem’s HealthSync Designated Orthopedic Network.
Elevance shares slip after insurer discloses suspension warning for Medicare prescription program
The U.S. Centers for Medicare and Medicaid Services alleges the Indianapolis-based health insurer has failed to properly submit required information to federal regulators since 2018.
IU Health surgeon among first to use new shoulder replacement technique
Dr. Jacob Triplet, at IU Health Ball Memorial Hospital in Muncie, recently began using the Stryker Mako SmartRobotics device — a robotic arm surgical system that assists him during a reverse shoulder replacement.
Elanco stock climbs as company issues favorable earnings report after product launches
Elanco Animal Health Inc. stock hit a 52-week high this week after the company posted double-digit revenue growth in the fourth quarter, driven by sales of some of its newest products.